Contact Us
Find A Doctor

Anterior Segment Imaging using UBM Clinical Trial

Principal Investigator 

Robert Ritch, M.D.


To detect differences in the iris thickness in patients on systemic alpha adrenergic blockers using UBM and SL-OCT


Patients on Flomax and that have used it in the past (for at least 6 months). Exclusion on Patients with any disease that could change iris morphology (uveitis, PDS, XFS, trauma...) or previous intraocular surgery.

Enrollment Goal

50 patients/ 50 controls (OPEN)


Contact Us

Glaucoma Associates of New York - Glaucoma Research InstituteTel: (212) 477-7540 ext 329

Address310 E. 14th Street
South Building, 5th Floor
New York, NY 10003

View all locations